Pfizer bivalent Covid shot linked to strokes in ppl 65 & older: Prelim data

The potential risk with Pfizer's vaccine was not seen in other safety databases, nor was it seen with Moderna Inc.'s Covid vaccine, the officials said in a statement

Pfizer
A person walks past a Pfizer logo amid the coronavirus disease pandemic in the Manhattan borough of New York City (Photo: Reuters)
Robert Langreth and Fiona Rutherford | Bloomberg
2 min read Last Updated : Jan 14 2023 | 10:30 AM IST
Pfizer Inc.’s bivalent shot for Covid-19 has shown a potential link to stroke in people 65 and older, according to US health officials citing preliminary data from one of several vaccine safety databases. 
 
The potential risk with Pfizer’s vaccine was not seen in other safety databases, nor was it seen with Moderna Inc.’s Covid vaccine, the officials said in a statement on the Food and Drug Administration’s website. The early finding still needs more investigation, and recommendations for the vaccine have not been changed, the statement said. 

“When we find a signal we look for it in other parts of the system, which is what we’ve done (and will continue to do),” Kristen Nordlund, a spokesperson for the Centers for Disease Control and Prevention, said in an email. 

The agencies said the possible link to stroke was seen in the CDC’s Vaccine Safety Datalink. Investigation of the signal raised a question of whether people 65 and older who received the Pfizer-BioNTech bivalent shot were more likely to have an ischemic stroke, a loss of blood flow in the brain, in the 21 days following vaccination compared with days 22-44 following vaccination, the agencies said in the statement.

“The totality of the data currently suggests that it is very unlikely that the signal in VSD represents a true clinical risk,” the statement said.

Pfizer’s bivalent booster is armed specifically to protect against two omicron variants, called BA4 and BA5. Messenger RNA Covid shots have been linked to pericarditis and myocarditis, inflammation of the heart and its surrounding tissue that’s usually mild.  

Pfizer and its partner BioNTech Se “have been made aware of limited reports of ischemic stroke” in the CDC Vaccine Safety DataLink database in people 65 and older following vaccination after the companies’ bivalent shot, a spokesperson said. There is no data to conclude that Pfizer’s vaccine is causally associated with stroke, the spokesperson said.

Among 550,000 people 65 and older who had been vaccinated and received the Pfizer bivalent booster, 130 had strokes in the first three weeks after getting the shot, according to the CDC, and no deaths have been reported.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPfizerCoronavirus Vaccine

Next Story